UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Corrigendum: Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study

Wiendl, H; Barkhof, F; Montalban, X; Achiron, A; Derfuss, T; Chan, A; Hodgkinson, S; ... De Stefano, N; + view all (2025) Corrigendum: Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study. [Corrigendum]. Frontiers in Immunology , 16 , Article 1571978. 10.3389/fimmu.2025.1571978. Green open access

[thumbnail of Corrigendum Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets results of .pdf]
Preview
Text
Corrigendum Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets results of .pdf - Published Version

Download (385kB) | Preview

Abstract

This article is a correction to: Blood Biomarker Dynamics in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study.

Type: Article
Title: Corrigendum: Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study
Location: Switzerland
Open access status: An open access version is available from UCL Discovery
DOI: 10.3389/fimmu.2025.1571978
Publisher version: https://doi.org/10.3389/fimmu.2025.1571978
Language: English
Additional information: Copyright © 2025 Wiendl, Barkhof, Montalban, Achiron, Derfuss, Chan, Hodgkinson, Prat, Leocani, Schmierer, Sellebjerg, Vermersch, Jin, Chudecka, Kloetgen, Lin, Gardner and De Stefano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY), https://creativecommons.org/licenses/by/4.0/. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Keywords: Multiple sclerosis, cladribine tablets, biomarkers, transcriptomics, immunophenotyping, immune reconstitution therapy
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
URI: https://discovery.ucl.ac.uk/id/eprint/10209003
Downloads since deposit
11Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item